CAS RN: 62512-19-0

1,1,1,1-Kestohexose, Analytical reference

Product Availability

Choose a grade to view its available package options.

8 package records7 with current stock2 grade groups
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260630 100mg In stock Shanghai Inquiry
Batchno.20250426 10mg In stock Shanghai Inquiry
Batchno.20250928 10mg / 50mg Confirm by inquiry Shanghai Inquiry
Batchno.20260227 250mg Out of stock Inquiry
Batchno.20260204 25mg In stock Shanghai Inquiry
Batchno.20250925 50mg In stock Shanghai Inquiry
Batchno.20260605 5mg In stock Shanghai Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250209 20mg In stock Shanghai Inquiry
  • Product code: SSC-171724
GET A QUOTE
Historical Factory Record

Historical Supply Reference

This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.

  • Pack sizes on record: 0.1g
  • Available purity: ≥95%
  • Inventory rows with stock: 0
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Reference Pack Sizes

Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 62512-19-0
Pack Size Recorded Purity Available Qty Ship From Inquiry
0.1g ≥95% 0 Out of Stock Beijing Inquiry

62512-19-0 / (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

Standard CAS: 62512-19-0 Multi CAS: Yes

Basic Information

CAS
62512-19-0
Multi CAS
Yes
Molecular Formula
C36H62O31
Molecular Weight
990.900000
Exact Mass
990.327505
InChI
InChI=1S/C36H62O31/c37-1-12-18(44)24(50)25(51)31(61-12)67-36(30(56)23(49)17(6-42)66-36)11-60-35(29(55)22(48)16(5-41)65-35)10-59-34(28(54)21(47)15(4-40)64-34)9-58-33(27(53)20(46)14(3-39)63-33)8-57-32(7-43)26(52)19(45)13(2-38)62-32/h12-31,37-56H,1-11H2/t12-,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23-,24+,25-,26+,27+,28+,29+,30+,31-,32-,33-,34-,35-,36+/m1/s1
InChIKey
BWRYDXSZCCQXIF-TWMOFSFSSA-N

Computed Properties

Structural Parameters

Heavy atom count
67
Fraction Csp3
1
Rotatable bonds
21
H-bond acceptors
31
H-bond donors
20
Molar refractivity
199.26
TPSA
506.13

LogP / Solubility

WLOGP
-14.09
MLOGP
-12.31
XLogP3
-11.1
Consensus LogP
-12.5
Log S (ESOL)
4.28
Class (ESOL)
Highly soluble
Log S (Ali)
2.49
Class (Ali)
Highly soluble
Log S (SILICOS-IT)
3.08
Class (SILICOS-IT)
Highly soluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-18.77

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Leadlikeness
No
Synthetic Accessibility
10

Get In Touch

Contact Us